[Federal Register Volume 67, Number 160 (Monday, August 19, 2002)]
[Notices]
[Page 53812]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-20997]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated March 29, 2001, and published in the Federal 
Register on April 6, 2001, (66 FR 18309) Ganes Chemicals Inc., which 
has changed its name to Siegfried (USA), Inc., Industrial Park Road, 
Pennsville, New Jersey 08070, made application by renewal to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Amobarbital (2125).........................  II
Pentobarbital (2270).......................  II
Secobarbital (2315)........................  II
Glutethimide (2250)........................  II
Methadone (9250)...........................  II
Methadone-intermediate (9254)..............  II
Dextropropoxyphene, bulk (non-dosage forms)  II
 (9273).
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
distribution as bulk products to its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Siegfried (USA), Inc. to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Siegfried (USA), on 
a regular basis to ensure that the company's continued registration is 
consistent with the public interest. These investigations have included 
inspection and testing of the company's physical security systems, 
audits of the company's records, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 
0.100 and 0.104, the Deputy Assistant Administrator, Office of 
Diversion Control, hereby orders that the application submitted by the 
above firm for registration as a bulk manufacturer of the basic classes 
of controlled substances listed above is granted.

    Dated: July 29, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-20997 Filed 8-16-02; 8:45 am]
BILLING CODE 4410-09-M